Loading clinical trials...
Loading clinical trials...
A Single-Center Exploratory Study to Evaluate the Safety and Efficacy of FKC288 in Subjects With Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis
Conditions
Interventions
FKC288
Locations
1
China
Jinling Hospital
Nanjing, Jiangsu, China
Start Date
August 29, 2023
Primary Completion Date
June 1, 2025
Completion Date
June 1, 2026
Last Updated
November 15, 2023
NCT06983951
NCT06971380
NCT01789242
Lead Sponsor
Nanjing University School of Medicine
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions